Susquehanna Fundamental Investments’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,037
Closed -$192K 536
2023
Q2
$192K Sell
14,037
-361
-3% -$5.17K 0.01% 577
2023
Q1
$221K Hold
14,398
0.01% 850
2022
Q4
$193K Sell
14,398
-16,424
-53% -$220K ﹤0.01% 1072
2022
Q3
$410K Buy
+30,822
New +$532K 0.01% 1073
2022
Q1
$267K Buy
+13,393
New +$270K 0.01% 1289
2021
Q3
Sell
-12,930
Closed -$373K 1840
2021
Q2
$373K Buy
+12,930
New +$350K 0.01% 1282
2020
Q4
Sell
-24,500
Closed -$426K 1573
2020
Q3
$426K Buy
24,500
+13,100
+115% +$280K 0.01% 937
2020
Q2
$299K Buy
+11,400
New +$283K 0.01% 742

Other funds holding PAHC

Susquehanna Fundamental Investments's PAHC Position: Q3 2023 in Review

Susquehanna Fundamental Investments sold out of Phibro Animal Health (PAHC) in Q3 2023, closing a stake of 14,037 shares — an estimated $192K sold.

Susquehanna Fundamental Investments first reported a position in PAHC in Q2 2020 and held it in 8 quarters. The position peaked at $426K in Q3 2020. 125 funds tracked by Wall St. Rank hold PAHC as of Q3 2023.

  • Susquehanna Fundamental Investments reported no remaining Phibro Animal Health position as of Q3 2023 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 14,037 Phibro Animal Health shares in Q3 2023, an estimated $192K.
  • Susquehanna Fundamental Investments first reported a position in Phibro Animal Health in Q2 2020 and held it in 8 quarters.
  • Susquehanna Fundamental Investments's Phibro Animal Health position peaked at $426K in Q3 2020.
  • 125 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2023, filed 14 Nov 2023.